News|Articles|November 2, 2001

Pharmaceutical Technology

  • Pharmaceutical Technology-11-02-2001
  • Volume 25
  • Issue 11

Outsourcing Outlook

Author(s)Jim Miller

The 2001 POMA Sourcing Survey declares 2001 a good year for drug development and manufacturing outsourcing.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.